- Home
- APLT vs MOBX Comparison
APLT vs MOBX Comparison
Compare APLT & MOBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- MOBX
- Stock Information
- Founded
- APLT 2016
- MOBX 2020
- Country
- APLT United States
- MOBX United States
- Employees
- APLT N/A
- MOBX N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- MOBX
- Sector
- APLT Health Care
- MOBX
- Exchange
- APLT Nasdaq
- MOBX Nasdaq
- Market Cap
- APLT 37.5M
- MOBX 31.4M
- IPO Year
- APLT 2019
- MOBX N/A
- Fundamental
- Price
- APLT $0.33
- MOBX $0.79
- Analyst Decision
- APLT Buy
- MOBX
- Analyst Count
- APLT 7
- MOBX 0
- Target Price
- APLT $6.10
- MOBX N/A
- AVG Volume (30 Days)
- APLT 2.3M
- MOBX 141.9K
- Earning Date
- APLT 04-14-2025
- MOBX 05-13-2025
- Dividend Yield
- APLT N/A
- MOBX N/A
- EPS Growth
- APLT N/A
- MOBX N/A
- EPS
- APLT N/A
- MOBX N/A
- Revenue
- APLT $455,000.00
- MOBX $9,326,000.00
- Revenue This Year
- APLT $3,031.87
- MOBX N/A
- Revenue Next Year
- APLT $312.01
- MOBX N/A
- P/E Ratio
- APLT N/A
- MOBX N/A
- Revenue Growth
- APLT N/A
- MOBX 1023.61
- 52 Week Low
- APLT $0.30
- MOBX $0.55
- 52 Week High
- APLT $10.62
- MOBX $3.62
- Technical
- Relative Strength Index (RSI)
- APLT 36.05
- MOBX 40.46
- Support Level
- APLT $0.30
- MOBX $0.76
- Resistance Level
- APLT $0.38
- MOBX $0.85
- Average True Range (ATR)
- APLT 0.05
- MOBX 0.09
- MACD
- APLT -0.00
- MOBX 0.01
- Stochastic Oscillator
- APLT 17.19
- MOBX 32.03
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About MOBX Mobix Labs Inc.
Mobix Labs Inc. specializes in designing, developing, and selling components and systems for wireless and wired connectivity, radio frequency (RF) technologies, switching, and electromagnetic interference (EMI) filtering solutions. The company serves markets, including commercial, industrial, automotive, medical, aerospace, defense, and others.